|
ZNF84 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.00169991693144E-10 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.10000938650046E-12 |
| Normal-vs-Stage2 |
1.521160E-03 |
| Normal-vs-Stage3 |
1.021830E-03 |
| Normal-vs-Stage4 |
1.662040E-03 |
| Stage1-vs-Stage2 |
3.840200E-01 |
| Stage1-vs-Stage3 |
9.676000E-03 |
| Stage1-vs-Stage4 |
9.184800E-03 |
| Stage2-vs-Stage3 |
3.411200E-01 |
| Stage2-vs-Stage4 |
3.498800E-01 |
| Stage3-vs-Stage4 |
9.670600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.49080011960734E-10 |
| Normal-vs-AfricanAmerican |
3.552100E-04 |
| Normal-vs-Asian |
1.481570E-02 |
| Caucasian-vs-AfricanAmerican |
9.970000E-01 |
| Caucasian-vs-Asian |
9.752600E-01 |
| AfricanAmerican-vs-Asian |
9.725600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.32809999664474E-08 |
| Normal-vs-Female |
2.63930000077295E-09 |
| Male-vs-Female |
3.699000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.043800E-02 |
| Normal-vs-Age(41-60Yrs) |
5.10349984494951E-10 |
| Normal-vs-Age(61-80Yrs) |
7.39569999685941E-08 |
| Normal-vs-Age(81-100Yrs) |
1.877240E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.703600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.043800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.450800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.574200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.455360E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.980000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.020490E-03 |
| Normal-vs-Grade 2 |
1.05360165036927E-13 |
| Normal-vs-Grade 3 |
1.74720000001294E-06 |
| Normal-vs-Grade 4 |
7.726800E-01 |
| Grade 1-vs-Grade 2 |
2.017400E-01 |
| Grade 1-vs-Grade 3 |
4.782400E-03 |
| Grade 1-vs-Grade 4 |
3.70599999999222E-06 |
| Grade 2-vs-Grade 3 |
6.803600E-04 |
| Grade 2-vs-Grade 4 |
5.9854998735176E-10 |
| Grade 3-vs-Grade 4 |
6.447200E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.00790511889682E-14 |
| Normal-vs-ccB subtype |
1.539070E-03 |
| ccA subtype-vs-ccB subtype |
2.06689999999732E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.68519999966099E-08 |
| Normal-vs-N1 |
7.747800E-01 |
| N0-vs-N1 |
9.536200E-02 |
|
|
